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Background: The Na-Ca2 exchanger isoform 3 (NCX3) participates in maintaining calcium homeostasis in brain and
skeletal muscle.
Results: The two splice variants of NCX3 have distinct regulation and capacity of exchange.
Conclusion: Distinct calcium uptake capacity of muscle NCX3 suggests a novel function in muscle exercise physiology.
Significance: This study brings a new understanding of the role of NCX3 variants in excitable tissues.
Isoform 3 of the Na-Ca2 exchanger (NCX3) is crucial for
maintaining intracellular calcium ([Ca2]i) homeostasis in
excitable tissues. In this sense NCX3 plays a key role in neu-
ronal excitotoxicity and Ca2 extrusion during skeletal mus-
cle relaxation. Alternative splicing generates two variants
(NCX3-AC and NCX3-B). Here, we demonstrated that NCX3
variants display a tissue-specific distribution in mice, with
NCX3-B as mostly expressed in brain and NCX-AC as pre-
dominant in skeletal muscle. Using Fura-2-based Ca2 imag-
ing, we measured the capacity and regulation of the two
variants during Ca2 extrusion and uptake in different con-
ditions. Functional studies revealed that, although both vari-
ants are activated by intracellular sodium ([Na]i), NCX3-AC
has a higher [Na]i sensitivity, as Ca2 influx is observed in
the presence of extracellular Na. This effect could be par-
tially mimicked for NCX3-B by mutating several glutamate
residues in its cytoplasmic loop. In addition, NCX3-AC dis-
played a higher capacity of both Ca2 extrusion and uptake
compared with NCX3-B, together with an increased sensitiv-
ity to intracellular Ca2. Strikingly, substitution of Glu580 in
NCX3-B with its NCX3-AC equivalent Lys580 recapitulated
the functional properties of NCX3-AC regarding Ca2 sensi-
tivity, Lys580 presumably acting through a structure stabiliza-
tion of the Ca2 binding site. The higher Ca2 uptake capac-
ity of NCX3-AC compared with NCX3-B is in line with the
necessity to restore Ca2 levels in the sarcoplasmic reticulum
during prolonged exercise. The latter result, consistent with
the high expression in the slow-twitch muscle, suggests that
this variant may contribute to the Ca2 handling beyond that
of extruding Ca2.
The Na-Ca2 exchanger (NCX)2 is a plasma membrane
transporter that plays a major role in the maintenance of Ca2
homeostasis in various cell types (1, 2). NCX catalyzes the
exchange of Na and Ca2 with a 3:1 stoichiometry (3).
Depending on the electrochemical gradient across the plasma
membrane NCX can either extrude intracellular Ca2 in its
forwardmode or take up extracellular Ca2 in its reversemode.
The NCX protein contains 10 transmembrane segments and a
large central intracellular loop (4–6). The latter was shown to
be responsible for the allostericmodulation of the exchanger by
Na and Ca2 (7). A high intracellular Na concentration
([Na]i) or low intracellular Ca2 concentration ([Ca2]i) inac-
tivates the reverse mode of the exchanger (7–9).
In mammals, the NCX family consists of three separate
genes: NCX1, NCX2, and NCX3 (10). NCX1 is predominantly
expressed in heart, kidney, and brain (11), NCX2 is most abun-
dantly expressed in brain (12), and NCX3 is expressed in excit-
able tissues such as brain and skeletal muscle (13). Numerous
splice variants of NCX1 exist in various species, whereas there
is only a single variant described for NCX2 (12). Finally, for
NCX3, six variants have been described in human (12, 14). In
mice, two variants of NCX3 have been identified, but data
regarding their expression pattern are lacking. It has, therefore,
been hypothesized that expression of mouse NCX3 variants
follows the same tissue distribution as that observed in rat (12).
This would imply that in mice NCX3-B is expressed in brain,
and NCX3-AC expression is restricted to the adult skeletal
muscle. These two NCX3 variants are derived from an alterna-
tive splicing of the exons A, B, and C. Given the fact that exons
A and B are mutually exclusive, the alternative splicing intro-
duces a difference of 24 residues between the NCX3-B and
NCX3-AC variants. All of these residues are located within the
cytoplasmic regulatory loop known to regulate the activity of
the exchanger (12).
The role of NCX3 in brain has been extensively studied. In
neurons, NCX3 plays an important role in pathological situa-
tions such as ischemia and excitotoxicity (15, 16). In skeletal
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muscle, NCX3 action constitutes the major Ca2 extrusion
mechanism during the relaxation process (17). Its absence
induces muscle necrosis and aberrant Ca2 homeostasis (18).
However, little is known about the regulation and functional
properties of NCX3-B and NCX3-AC.
The aim of the present study was to gain insight into the
properties and physiological role of NCX3-B and NCX3-AC.
To this end, the expression of both variants in various mouse
tissues was assessed. Next, we investigated whether the amino
acid differences in the regulatory loop of both NCX3 variants
have functional consequences. Therefore, NCX3-AC and
NCX3-B were expressed at the plasma membrane in human
embryonic kidney (HEK293T) cells. Subsequently, the regula-
tion of the NCX3 variants by [Ca2]i and [Na]i was studied
using Fura-2-based Ca2 imaging. Finally, the same approach
was applied to site-directed mutants to investigate the molecu-
lar mechanisms that give rise to the differences in exchange
activity.
EXPERIMENTAL PROCEDURES
cDNA Cloning—Murine NCX3-B (kindly provided by Prof.
Geerten Vuister, Leicester, UK) was subcloned into the XhoI
and NheI sites of the bicistronic mammalian vector pCINeo
containing an internal ribosome entry site and enhanced green
fluorescent protein. An HA tag was added to the N terminus of
the NCX protein. Fragments corresponding to exons AC or B
were obtained by amplification of cDNA from mice hind limb
skeletal muscle using a high fidelity DNApolymerase (Phusion,
Thermo Fisher). The uncut fragment, containing only NCX3-
AC, after digestion with XmnI was subcloned into the BlpI and
XhoI sites of NCX3-B pCINeo vector. The D1ER calcium sen-
sor targeted to the endoplasmic reticulum (ER) was inserted in
a pcDNA3. Following transformation, the plasmids were tested
by the action of two-cutter restriction enzymes and subse-
quently checked by sequencing.
Mutagenesis—All NCX3-B mutants were generated using a
QuikChange site-directedmutagenesis kit (Stratagene, La Jolla,
CA) following the manufacturer’s instructions. All mutants
were subsequently validated by Sanger sequencing.
Expression Profile and Quantitative Real-time Polymerase
Chain Reaction Analysis—Three C57BL/6 mice were sacri-
ficed. The brain, heart, and four different skeletal muscles from
the hind limb were collected: gastrocnemius, soleus, extensor
digitorum longus, and tibialis anterior. Tissue RNA was
extracted using TRIzol total RNA isolation reagent (Life Tech-
nologies BRL, Breda, TheNetherlands). After DNase treatment
(Promega, Madison,WI), 1g of RNAwas reverse-transcribed
byMoloneymurine leukemia virus reverse transcriptase (Invit-
rogen) as described previously (19). Using a CFX96 Real time
PCR detection system (Bio-Rad), three calibration curves cor-
responding to NCX3-AC, NCX3-B, and total NCX3 were real-
ized using serial dilutions of pCINeo-NCX3-B and pCINeo-
NCX3-AC. The cDNA from tissues were used to measure
the absolute copy number per g of mRNA. The sequences
were amplified using the following primers: total NCX3,
5-ATATGGGGAGCTGGAGTTCA-3 (forward) and 5-CTG-
GAGATAACAGGAGCGC-3 (reverse), NCX3-AC, 5-GGGC-
CCCCGCATGGTGGATA-3 (forward) and 5-CAGCTTCCT-
GTCTGTCACTTCTGGA-3 (reverse), andNCX3-B, 5-GCAT-
ATGGGGAGCTGGAGT-3 (forward) and 5-GTTCACCAAG-
GGCAATGAAG-3 (reverse).
Expression of Na/Ca2 Exchanger in Human Embryonic
KidneyCells—Human embryonic kidney cells (HEK293T)were
grown in Dulbecco’s modified Eagle’s medium (BioWhittaker-
Europe, Verviers, Belgium) containing 10% (v/v) fetal calf
serum and 2 mM L-glutamine at 37 °C with 5% (v/v) CO2. The
cells were seeded on a six-well plate and transiently transfected
with the respective constructs (2 g/well) using polyethyleni-
mine cationic polymer PEI (Polysciences, Inc., Warrington,
PA) in accordance with the manufacturer’s instructions. The
HEK293T cells were used for the experiments 48 h after
transfection.
Cell Surface Biotinylation—Cell surface labeling with biotin
was performed using the sulfo-NHS-LC-LC-biotin (0.5 mg/ml,
Thermo Fisher Scientific, Rockford, IL) as described previously
(20). Cells from each six-well plate were homogenized on ice in
0.5 ml of lysis buffer (150 mM NaCl, 5 mM EDTA, 0.5% (v/v)
Triton X-100 (v/v), protease inhibitors, 50 mM Tris/HCl, pH
7.5) to prevent endo- and exocytosis, as described previously
(21). Subsequently 5% (v/v) of the total protein amount was
collected as an input sample. Next, biotinylated proteins
(plasmamembrane fraction) were precipitated using Neutravi-
din-agarose beads (Thermo Fisher). Biotinylated fractionswere
eluted in 2 Laemmli buffer containing 100 mM dithiothreitol
and proteinase inhibitors (22). Finally, samples were denatured
for 30 min at 37 °C. NCX3-B and NCX3-AC expression was
analyzed by immunoblot analysis for the input and the plasma
membrane fraction (23).
Immunoblot Analysis—Lysateswere subjected to SDS-PAGE
8% (w/v) and electroblotted onto PVDFmembranes. Blots were
incubated with 5% (w/v) nonfat dried milk in TBS-T (137 mM
NaCl, 0.2% (v/v) Tween 20, and 20 mM Tris/HCl, pH 7.6).
Immunoblots were incubated overnight at 4 °C with a rabbit
anti-NCX3 antibody (1:3000) (kindly provided by Prof. Ken-
neth Philipson, UCLA) (24) diluted in 1% (w/v) milk in TBS-T.
PVDF membranes were incubated 1 h at room temperature
with a sheep horseradish peroxidase-conjugated anti-rabbit
(1:10000) (Sigma) in TBS-T. Afterward, blots were visualized
using the enhanced chemiluminescence system (ECL, Thermo
Fisher).
[Ca2]i and [Ca2]ER Measurements—48 h after transfec-
tion, cells were loaded with 3 M Fura-2 acetoxymethyl ester
(Fura-2/AM) and 0.01% (v/v) Pluronic F-127 for 20min at 37 °C
inKrebs solution (5.5mMKCl, 147mMNaCl, 1.2mMMgCl2, 1.5
mM CaCl2, 10 mM glucose, and 10 mM HEPES/NaOH, pH 7.4).
Then, the cells were washed with Krebs medium for 10 min.
Finally the coverslips were placed into a perfusion chamber
mounted onto the stage of an invertedmicroscope (Zeiss Axio-
vert 200 M, Carl Zeiss, Jena, Germany). Changes inmedium and
addition of inhibitors were facilitated using a perfusion system.
[Ca2]iwasmonitored by exciting Fura-2withmonochromatic
light of wavelength 340 and 380 nm (Polychrome IV, TILL Pho-
tonics, Gräfelfing, Germany). Fluorescence emission light was
directed by a 415DCLP dichroic mirror (Omega Optical, Inc.,
Brattleboro, VT) through a 510WB40 emission filter (Omega
Optical, Inc.) onto aCoolSNAPHQmonochromeCCDcamera
NCX3 Splice Variants in Brain and Skeletal Muscle
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(Roper Scientific, Vianen, The Netherlands). The integration
time of the CCD camera was set at 200 ms with a sampling
interval of 3 s. [Ca2]ER was monitored on cells co-expressing
D1ER in a pcDNA3 vector and NCX3 variants in a pCINeo
vector lacking the internal ribosome entry site enhanced GFP.
cerulean fluorescent protein (CFP) was excited with mono-
chromatic light at 450 nm. Fluorescent emission light was
directed by a 455DRLP Dichroic mirror (Omega Optical, Inc.)
through 480AF30 and 535AF26 emission filters. All hardware
was controlled with Metafluor software (version 6.0, Universal
Imaging Corp., Downingtown, PA). During Fura-2 measure-
ments, enhanced GFP-positive cells were selected as trans-
fected cells. During D1ER measurements, CFP-positive cells
were selected as cotransfected cells (25). For each wavelength,
the mean fluorescence intensity was monitored in an intracel-
lular region and, for purpose of background correction, in an
extracellular region of identical size. After background correc-
tion, the fluorescence emission ratio (340 nm/380 nm) and (530
nm/480 nm) was calculated to determine the Fura-2 and the
D1ER ratios, respectively. Eight to 15 individual cells were
selected and monitored simultaneously from each coverslip.
NCX activity was evaluated as Ca2 uptake through the reverse
mode by switching the normal Krebs medium to a Na-free
NMDG medium containing: 5.5 mM KCl, 147 mM N-methyl
glucamine, 1.2mMMgCl2, 1.5mMCaCl2, 10mMglucose, and 10
mM HEPES/HCl, pH 7.4 (15). The effect of an increase in
[Ca2]i and [Na]i was investigated by applying an irreversible
and selective inhibitor of the sarcoplasmic reticulumCa2-AT-
Pase (thapsigargin, 1 M) or using an inhibitor of the Na-K
ATPase (ouabain, 1 M) incubated 60 min prior to the experi-
ment and perfused during recordings as described previously
(15). Additionally, the forwardmode of the exchanger was eval-
uated by measuring the capacity to perform Ca2 extrusion
after an increase induced by acute addition of the Ca2 iono-
phore (ionomycin, 1M) inCa2-free conditions.Osmolality of
all buffers has been measured to ensure a difference smaller
than 5 mosM. All buffers were kept at 37 °C.
Analysis of the [Ca2]iMeasurements—After initiation of the
reverse mode, varying Ca2 uptakes were observed in the dif-
ferent conditions. For each condition, the baseline value was
calculated as an average of the first 60 s of recording. During
investigation of the forward mode, the baseline Fura-2 ratio
recorded in mock-expressing cells in Ca2-free medium was
subtracted from themaximal Fura-2 ratio in the same cells after
ionomycin treatment. This calculation represents the maxi-
mum amount of Ca2 that is present in the ER and that could
potentially be extruded via NCX3. Next, the experimental
extrusion of Ca2 was calculated as follow: the difference
between the mock and the given condition (NCX3-AC,
NCX3-B, or mock) both after addition of ionomycin. This dif-
ference was reported as a percentage of the theoretical maxi-
mum extrusion value described above. This difference is subse-
quently expressed as a percentage of the theoretical maximal
value. During the experiments in absence of thapsigargin or
ouabain, the cells responding to a removal of extracellular Na
were quantified, by taking the Fura-2 ratio value of 0.4 as a
threshold of responsiveness.
Drugs and Chemicals—Ionomycin and thapsigargin were
purchased from Sigma; ouabain was fromMPBiomedicals; and
Fura-2-AM and pluronic acid were from Invitrogen. All were
dissolved in dimethyl sulfoxide. The final concentration of
dimethyl sulfoxide was 0.1% (v/v) and had no effect on [Ca2]i.
Statistical Analysis—All results are based on at least three
different sessions of experiments. The Fura-2 ratio is an average
of 65 individual cells. Values are expressed as means  S.E.
Statistical significance (p  0.05) was determined using one-
way analysis of variance with Bonferroni’s procedure.
RESULTS
Expression Profile of NCX3-B and NCX3-AC in Excitable
Tissues—Toelucidate the expression ofNCX3variants in excit-
able tissues, the mRNA expression of NCX3-B and NCX3-AC
was quantified in brain, heart, and skeletal muscles. Type I and
type II skeletal muscle fibers confer slow-twitch and fast-twitch
properties to themyofibers, respectively. In this study, four dif-
ferent skeletal muscles were selected: soleus and extensor digi-
torum longus for their predominantly constitution of type I and
type II fibers, respectively, tibialis anterior, and gastrocnemius
for their mixed constitution of fibers in mammals (26). Due to
high sequence homology between the two variants, primers
were designed to anneal specifically to the alternatively spliced
regions corresponding to exons B and AC (Fig. 1, a and b). A
third set of primers was designed to measure the expression of
both NCX3 variants. Quantification of total NCX3 expression
showed low levels in cardiac tissue, whereas a high expression
was measured in brain (Fig. 1c). Among the different skeletal
muscles, NCX3 was more abundantly found in the slow-twitch
muscle fibers constitutive of the soleus than in the fast-twitch
or mixed fibers with a 6 to 10-fold difference. In the brain, the
expression of NCX3-B was 3-fold higher than NCX3-AC (Fig.
1d). In soleus, the opposite trend was observed with NCX3-AC
being 3-fold higher than NCX3-B. In the fast-twitch skeletal
muscles, NCX3-B was poorly expressed, whereas NCX3-AC
expression levels appeared to be6-fold higher.
Both NCX3 Variants Display Reverse Mode Exchange Activity—
Next, the investigation of NCX3 functional activity was per-
formed using HEK293T cells transfected with NCX3-AC,
NCX3-B, or empty vector (mock). The activity of these
exchangers was assessed bymeasuring changes in [Ca2]i using
the ratiometric probe Fura-2. Under resting conditions, basal
[Ca2]i was similar in NCX3-AC, NCX3-B, and mock-trans-
fected cells (Fig. 2a). Thapsigargin has been shown to induce a
rise in [Ca2]i and consequently fully activatesNCX (27). Addi-
tion of thapsigargin (1 M) increased [Ca2]i in all three condi-
tions (Fig. 2a). However, this increase was significantly lower in
cells expressing NCX3-AC (Fig. 2b) compared with the other
conditions. Removal of extracellular Na was used to energize
Ca2 uptake via the reverse mode of NCX. This protocol
yielded an increase in [Ca2]i in cells expressingNCX3-AC and
NCX3-B (Fig. 2c), indicating reversemode of exchange activity.
Strikingly, the increase in [Ca2]i was 3-fold higher in cells
expressing NCX3-AC than NCX3-B. Mock-transfected cells
failed to respond, indicating that the endogenous NCX
expressed in HEK293T cells could not be detected with our
method. Cell surface quantification of NCX3 confirmed that
NCX3 Splice Variants in Brain and Skeletal Muscle
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FIGURE1.NCX3splicevariants and their tissueexpression.A, alternative splicingof themiceNa/Ca2exchanger isoform3pre-mRNAand the twovariants
obtained after alternative splicing of the exons A, B, and C. B, alignment of amino acid sequences in alternatively spliced NCX3 exons in themice NCX3-AC and
NCX3-B using ClustalW software. Missing residues are indicated by dashes. Symbols below the sequence indicate conserved (period) highly conserved (colon)
and identical residues (asterisk). C, NCX3 mRNA levels in different mice tissues. Total NCX3 (black), NCX3-B (gray), and NCX3-AC (white) transcript expression
levelswere quantifiedby real-timePCR.mRNAcopynumberswere calculated from theNCX3 standard curves generatedbyusing adilutedpCINeo-IRES-eGFP-
mNCX3-AC and pCINeo-IRES-eGFP-mNCX3-B vectors. Heart has been used as a negative control to show the absence of NCX3. eGFP, enhanced GFP; IRES,
internal ribosome entry site. EDL, extensor digitorum longus.
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both variants were similarly expressed at the plasmamembrane
(Fig. 2d).
Forward Exchange Activity of NCX3-AC Is Most Sensitive to
Intracellular Ca2—Furthermore, to explain the reduced
increase in [Ca2]i upon addition of thapsigargin inNCX3-AC-
expressing cells (Fig. 2b), we hypothesized that the forward
mode of NCX3-AC would be more active, leading to a smaller
apparent increase in [Ca2]i compared with NCX3-B-express-
ing cells. In the absence of extracellular Na and Ca2, condi-
tions under which the forward mode is abolished, the Ca2
level in the ER and the change in [Ca2]i in response to thapsi-
gargin, were similar in all cells (Fig. 3, a–d).
To strengthen our hypothesis, the forward mode was trig-
gered by perfusing the cells with the Ca2 ionophore ionomy-
cin (1 M) in the presence of extracellular Na. Under these
conditions, ionomycin allows for a complete release of Ca2 in
a fast manner from the ER to the cytoplasm, thereby inducing
an activation of NCX in its forward mode of exchange. Upon
addition of ionomycin, an increase in [Ca2]i was recorded in
the control condition (Fig. 3e). This rise in [Ca2]i was greatly
diminished in both variants of NCX3, confirming the extrusion
of Ca2 via the forward mode of the exchanger. The forward
mode activity, expressed as the ability to extrude Ca2, was
significantly larger for NCX3-AC than for NCX3-B (78  9%
and 47 11%, respectively, p 0.05) (Fig. 3f).
The Activity of NCX3-AC in Reverse Exchange Is Higher Than
NCX3-B—Fig. 2,a and c, show thatNCX3-B andNCX3-ACcan
both operate in the reverse mode and that NCX3-AC induces a
larger increase in [Ca2]i. The capacity of the reverse mode of
the NCX3 variants was then investigated by adding thapsi-
gargin in the absence of extracellular Na, thus preventing a
contribution from NCX3 in its forward mode. In these condi-
tions, [Ca2]i rose (Fig. 4a) in accordance with the pattern seen
previously after addition of thapsigargin (Fig. 2a). The increase
in [Ca2]i observed after the switch to the Na-free condition
was significantly higher in NCX3-AC compared withNCX3-B-
expressing cells (Fig. 4b), pinpointing either a lower sensitivity
of NCX3-B to [Ca2]i or a poor sensitivity to extracellular
[Na].
Nevertheless, theCa2uptake observed inNCX3-B-express-
ing cells under removal of extracellular Na (Fig. 4a) was not
detected in the absence of thapsigargin (Fig. 4c), demonstrating
the importance of intracellular Ca2 in the activation of this
variant. In the case of NCX3-AC, a low average was observed
(Fig. 4c), suggesting a poor activation of the reversemode. Nev-
ertheless, considering the cells separately, 45% of the NCX3-
AC-expressing cells appeared to respond strongly to a change
in Na gradient (Fig. 4d). This effect was less frequent for
NCX3-B andmock cells, a response being observed in 7 and 1%
of measured cells, respectively (data not shown).
High Sensitivity of NCX3-AC Reverse Mode to Intracellular
Na—To investigate the regulation of NCX3 in the reverse
mode by intracellular [Na], Fura-2 ratios were recorded fol-
lowing incubation of NCX3-AC and NCX3-B-expressing cells
with ouabain (1 M, 60 min), a Na,K-ATPase inhibitor that
has been shown to induce a rise in [Na]i (28). An activity in
reverse mode was observed for both variants upon removal of
extracellular Na. In both cases, this activity was higher than
the one recorded during activation by the increased [Ca2]i
(Figs. 4a and 5a). Additionally, the maximum Fura-2 ratio of
NCX3-AC in these conditions was found to be significantly
higher than recorded in the variant B (Fig. 5c).
Surprisingly, after incubation with ouabain, the basal [Ca2]i
measured in NCX3-AC-expressing cells was found to be very
close to the maximum value recorded in the absence of extra-
cellular Na (Fig. 5a), as demonstrated by the low increase in
[Ca2]i provoked by the removal of extracellular Na. The
Fura-2 ratio in the presence of extracellular Na was observed
to be already four times greater than NCX3-B (Fig. 5b). This
effect was not observed upon activation by intracellular Ca2
(Fig. 4a) or in the NCX3-B-expressing cells for which removal
of extracellular Na seems to be required for the activation of
the exchanger. The activation of NCX3-AC by intracellular
[Na], in high extracellular Na condition, demonstrates a
much greater sensitivity than NCX3-B to intracellular Na.
Molecular Determinants of the Na and Ca2 Sensitivity of
NCX3 Variants—The data recorded in Fig. 4 and 5 demon-
strated that the NCX3-AC variant is more sensitive to intracel-
lular Ca2 and Na. To get a better understanding of the
molecular mechanisms responsible for this increased sensitiv-
ity, the role of several residues of the alternatively spliced region
of NCX3 variants was investigated. This region, located in the
intracellular loop,within theCa2-binding domain 2 (CBD2) of
the protein, differs significantly from one variant to the other.
For instance, negatively charged residues such as glutamate and
aspartate found in NCX3-B sequence are absent in NCX3-AC
(Fig. 6a). These residues have been shown to participate in the
formation of theCa2-binding site ofNCX1 (29). Furthermore,
at these positions, several positively charged residues are pres-
ent in the variant AC, residues that are described in the case of
NCX1 as critical for stabilization of the tertiary structure of the
CBD2 (30, 31).
To study the possible role of these residues in the regulation
of the exchanger, site-directed NCX3-B mutants were gener-
ated targeting different glutamate residues (Fig. 6a) E573D,
E574K, E575A, E580K, and E588G. The different mutants were
subjected to recording of the forward and the reverse mode by
applying the similar protocols as described in the aforemen-
tioned paragraphs. Interestingly, E580K NCX3-B displayed
similar properties compared with NCX3-AC in both forward
and reverse mode (Fig. 6, b and c) triggered by an elevation in
[Ca2]i. With respect to the activation of the reverse mode
through a rise in [Na]i, the measurements of the Fura-2 ratio
at basal and maximum level revealed a significant increase in
the sensitivity to [Na]i in Na conditions for four of the five
mutants tested (Fig. 6d). In the absence of extracellular Na,
only the mutation E573D showed a significant increase in the
maximum [Ca2]i recorded (Fig. 6e). However, the four muta-
tions accounting for the increase seen in Fig. 6d displayed, in
Na-free conditions, a trend toward a Ca2 influx similar to
NCX3-AC. Furthermore, the comparison between NCX3-AC
and the three mutations E573D, E574K, and E580K did not
reveal any significant difference. Note that in all four condi-
tions, E588G NCX3-B showed no difference in its capacities
compared with NCX3-B.
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DISCUSSION
In the present study, we show, for the first time, functional
recordings of the variant NCX3-AC. These recordings indicate
a higher capacity of this variant in reverse and forwardmode of
exchange compared with NCX3-B. A difference that can be
fully attributed to the intrinsic properties of both variants con-
sidering that the plasma membrane expression in HEK293T
cells did not differ between the two variants and that the Ca2
level in the endoplasmic reticulumwere similar in these cells as
proven by the thapsigargin addition in absence of extracellular
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Na and Ca2. Furthermore, the reduced [Ca2]imeasured in
NCX3-AC-expressing cells upon thapsigargin addition com-
pared with NCX3-B, together with the activation of NCX3-AC
reverse mode in absence of an elevation in [Ca2]i suggest a
higher sensitivity of NCX3-AC to changes in [Ca2]i. Thereby,
a value slightly above the [Ca2]i recorded during the resting
state is sufficient to trigger the exchanger.
The lower sensitivity of NCX3-B to [Ca2]i, in bothmodes of
exchange, could be suppressed by mutating the glutamate res-
idue at position 580. This gain of sensitivity observed in the
E580K NCX3-B mutant reveals that the activation by Ca2 of
the forward and reverse mode of the exchanger is regulated
through the same site forwhich the residue 580 represents a key
residue. In NCX1, the equivalent residue Lys585 is involved in
the formation of a salt bridge that, in Ca2-free conditions,
stabilizes the Ca2-binding site I and II through the preserva-
tion of the tertiary structure (29, 32). NCX1 mutation of this
lysine into a glutamate causes a drop in the Ca2 affinity (29,
32). InNCX3-AC, Lys580 confers to the site I of theCBD2 a high
affinity forCa2 (31–33). In contrast, this variant has twoCa2-
binding sites in its Ca2-binding domain 2, whereas isothermal
titration calorimetry measurements showed that NCX3-B has
three Ca2-binding sites (30, 33). However, none of these Ca2
sites featured a high affinity forCa2 (33).Our data concurwith
the literature in suggesting that during a rise in [Ca2]i, the
high-affinity site I of NCX3-ACCBD2will bind Ca2 at a lower
concentration than NCX3-B. This could result in a disruption
of the salt bridge at Lys580 as hypothesized for NCX1 (29) and,
therefore, in an activation of the exchanger at lower [Ca2]i.
Another important finding from the current study is that
NCX3-B displayed a higher Na-dependent inactivation, given
that only the reverse mode of NCX3-AC could be activated,
during a rise in [Na]i in presence of extracellular Na. The
partial suppression of this effect by mutating glutamate resi-
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dues suggests that the hydrophilic domain found between posi-
tions 572 and 580 in the CBD2 domain is involved in this inac-
tivation. For NCX1, it has been demonstrated that the
alternative splicing of the same region can alleviate theNa-de-
pendent inactivation (34, 35). Moreover, D578R and K585C
mutations in NCX1, corresponding to positions 573 and 580 in
NCX3, reversed the Na-dependent inactivation in a complete
and partial manner, respectively (36). The emerging hypothesis
concerning the functioning of this Na-dependent inactivation
is a regulation by the Ca2-binding site of the CBD2 through
proximitywith the catenin-like domain of the protein (32). This
domain, formed by residues of the intracellular loop outside of
CBD1 and CBD2, would control the Na-dependent inactiva-
tion. Our results are consistent with the hypothesis predicting
that E573D, E574K, E575A, and E580K NCX3-B are responsi-
ble for the partial disruption of a Ca2-binding site that will
alter the interactionwith the catenin-like domain of the protein
and, therefore, lower the Na-dependent inactivation.
The tissue-specific distribution observed for the two variants
of NCX3, with NCX3-B as mostly expressed in the brain and
with NCX3-AC as themain variant detected in skeletal muscle,
is consistent with the functional properties measured for these
variants. In neurons, NCX3-B and its low capacity to perform
Ca2 uptake would have a protective effect against severe Ca2
overload, a phenomenon that could have dramatic conse-
quences on neurons.With this respect, the low sensitivity to an
increase in [Na]i would confer this preservation during the
firing of neurons. In the samemanner, activation of the forward
mode of NCX3-B requires a substantial rise in [Ca2]i. This
feature would have the same protective effect and yet will not
interferewith the synaptic activity, highly dependent on [Ca2]i
(37).
In skeletalmuscle, sensitivity to [Ca2]i and the high capacity
of NCX3-AC in the forwardmode corroborates with the neces-
sity in such fibers to activate the Ca2 extrusion as soon as the
contraction starts. Moreover, the high sensitivity of NCX3-AC
to changes in [Na]i and its high capacity to perform Ca2
uptake in reverse mode suggest that NCX3-AC might have
additional implications via its reversemode. The operation and
relevance of the reverse mode has been previously observed for
several members of the NCX family in numerous tissues, in
both physiological (38–40) and pathological situations (41, 42).
From another angle, during prolonged exercise, extracellular
Ca2 has been shown to have a beneficial effect on the resist-
ance to muscle fatigue, an effect that could only be observed in
slow-twitch muscle, similar to soleus, dedicated to this type of
prolonged exercise (43, 44). Together with the high expression
of NCX3-AC observed in soleus, these results suggest that
NCX3-AC might be implicated in Ca2 influx in slow-twitch
muscle, a hypothesis consistent with the findings fromDanieli-
Betto’s group (44). Here, the Ca2-free conditions provoke a
dramatic increase of muscle fatigue in soleus, an effect also
obtained by inhibition of NCX. This is also in accordance with
the increased fatigability observed in NCX3/mice (18). The
underlyingmechanism linking Ca2 uptake andmuscle fatigue
is still poorly understood but presumably involves a refilling of
the SR Ca2. Many variants of the NCX family are already
known to contribute to this latter process (45, 46), particularly
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in excitable cells (47–49). Therefore, NCX3 could in principle
be involved in this process in slow-twitchmuscle. Nevertheless,
our study was only performed in HEK 293 cells, albeit a well
used cell model to study mechanistic properties and ionic reg-
ulation of NCX isoforms (35, 50, 51). Therefore, confirmation
of the latter hypothesis needs further investigations using mus-
cular excitable tissue, in particular in soleus.
In conclusion, two variants of NCX3, which depict a tissue-
specific distribution among excitable tissues, have distinct
propertieswith regard to capacity of exchange and sensitivity to
[Ca2]i and [Na]i, with NCX3-AC functioning with a greater
capacity in all situations. Our data indicated that NCX3-AC is
the main variant expressed in skeletal muscle with a high
expression in soleus, a muscle in which NCX have been shown
to be implicated in the resistance to fatigue (44). Additionally,
our results are, to the best of our knowledge, the first functional
recordings of NCX3-AC and provides evidence of a high capac-
ity to achieve Ca2 influx that can be triggered by a simple
FIGURE 6. Glutamate residues are key regulators of Ca2 and Na sensitivity in NCX3-AC. A, alignment of the amino acid sequences of the mutually
exclusive exon A/B of NCX3-B to NCX3-AC. Missing residues are indicated by dashes. Specific NCX3-B single mutants were generated from corresponding
amino acid of NCX3-AC (indicated by an arrow). *, p 0.05 (B–E). B, mean values of themaximum Fura-2 ratio recorded during forwardmode followed by the
addition of ionomycin (1M) in Ca2-free conditions in cells expressing NCX3-AC, NCX3-B, or mutants of NCX3-B. NCX3-B, n 108; NCX3-AC, n 116; E573D
NCX3-B, n 93; E574K NCX3-B, n 110; E575A NCX3-B, n 82; E580K NCX3-B, n 90; E588G NCX3-B, n 110. C, mean values of the maximum Fura-2 ratio
in reverse mode triggered by the switch to Na-free medium containing 1M thapsigargin. Values were recorded in HEK293T cells expressing NCX3 variants
andmutants of NCX3-B. NCX3-B, n 102; NCX3-AC, n 120; E573D NCX3-B, n 77; E574K NCX3-B, n 110; E575A NCX3-B, n 121; E580K NCX3-B, n 86;
E588GNCX3-B, n 102.D and E, Fura-2 ratio recorded during reversemode triggered by 1-h treatment with ouabain (1M) in NCX3-AC, NCX3-B, and NCX3-B
mutants expressingHEK293T cells. NCX3-B,n99;NCX3-AC,n88; E573DNCX3-B,n86; E574KNCX3-B,n76; E575ANCX3-B,n122; E580KNCX3-B,n
123; E588GNCX3-B,n 99;D, mean values of Fura-2 ratio at thebaseline and averageof the first 60 s of the experiment in 147mMNamedium. E, mean values
of the maximum Fura-2 ratio after the switch to Na-free medium during the same experiment as described in D.
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increase in [Na]i. This exchanger might, therefore, play a role
in the resistance to muscle fatigability observed in the slow-
twitch muscle. Altogether, this study provides insights into the
ionic regulation of NCX3 through its alternative splicing in a
tissue-specific manner. In fact, the two variants may contribute
to Ca2 handling beyond their role in Ca2 extrusion.
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